BGM is the ticker symbol for BGM Group Ltd., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks BGM with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is BGM a good stock to buy?

BGM is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/BGM.

Where does 13F Pro source BGM data?

All BGM Group Ltd. fundamentals and ownership data come directly from SEC EDGAR. BGM Group Ltd. files with the SEC under CIK 1779578. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

BGM Group Ltd.(BGM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-09-30.

BGM Group Ltd. (BGM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BGM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 14 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), BGM Group Ltd. reports quarterly revenue of $37.9M, net income of $-19.9M, free cash flow of $-3.9M. Top institutional holders of BGM by reported 13-F value include GEODE CAPITAL MANAGEMENT, XTX Topco Ltd, UBS Group AG, based on the most recent SEC filings. BGM trades on the Nasdaq exchange and files with the SEC under CIK 1779578. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BGM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BGM Group Ltd. directly from SEC EDGAR.

Revenue

$37.9M

Net Income

$-19.9M

Free Cash Flow

$-3.9M

BGM key financials by period

BGM Group Ltd. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	20-F	$37.9M	$-19.9M	-33.2%
FY 2024	20-F/A	$25.1M	$-1.4M	-2.3%
FY 2023	20-F/A	$46.5M	$-7.8M	-5.6%
FY 2022	20-F	$64.9M	$1.1M	3.2%
FY 2021	20-F/A	$57.1M	$3.1M	4.2%
FY 2020	20-F	$50.0M	$5.1M	9.6%

Institutions holding BGM

Institutional investors reporting a position in BGM Group Ltd. on SEC Form 13F.
Institution	Shares	Value	Reported
GEODE CAPITAL MANAGEMENT	98,472	$36.2K	2026-06-30
XTX Topco Ltd	63,089	$23.2K	2026-06-30
UBS Group AG	57,646	$21.2K	2026-06-30
JANE STREET GROUP	57,227	$21.0K	2026-06-30
Virtu Financial	54,207	$20.0K	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	32,067	$11.8K	2026-06-30
Ground Swell Capital	11,101	$4.1K	2026-06-30
ROYAL BANK OF CANADA	1,499	$1.0K	2026-06-30
JPMORGAN CHASE	1,815	$681.00	2026-06-30
MORGAN STANLEY	200	$74.00	2026-06-30

SEC EDGAR: CIK 1779578 →

BGM Group Ltd.

BGM

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 14 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.